Establishment of an oriP/EBNA1-based episomal vector transcribing human genomic β-globin in cultured murine fibroblasts

被引:35
作者
Black, J
Vos, JM
机构
[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA
[2] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC USA
关键词
gene therapy; beta-globin; OriP; EBNA1; episomal maintenance;
D O I
10.1038/sj.gt.3301808
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel oriP/EBNA1-based episomal vector has been constructed that persists episomally in cultured murine fibroblasts. The vector, pBH148, is equipped with the entire 185kb human beta-globin gene locus. After amplification in bacteria, column-purified episomal pBH148 was transfected into both cultured EBNA1-expressing human D98/Raji positive control fusion cells (DRpBH 148) and cultured EBNA1-negative murine fibroblast cells (A9pBH148). Cell cultures were maintained concurrently with and without hygromycin selection for a period of 3 months. We show long-term stable episome maintenance of the full-size 200-kb circular double-stranded pBH148 in both the DRpBH148 cultures and the A9pBH148 cultures, regardless of selective pressure by agarose gel electrophoresis and Southern blot. EBNA 1 transgene was detected by PCR in all transfected cultures. In addition, we were able to detect correctly spliced human beta-globin mRNA by RT-PCR in all transfected late-passage DRpBH148 and A9pBH148 cell cultures. These findings illustrate that this oriP/EBNA1-based episomal vector is stable in a previously nonpermissive murine cell line and is a potential vector for human gene therapy.
引用
收藏
页码:1447 / 1454
页数:8
相关论文
共 58 条
[1]   PARTICIPATION OF THE HUMAN BETA-GLOBIN LOCUS-CONTROL REGION IN INITIATION OF DNA-REPLICATION [J].
ALADJEM, MI ;
GROUDINE, M ;
BRODY, LL ;
DIEKEN, ES ;
FOURNIER, REK ;
WAHL, GM ;
EPNER, EM .
SCIENCE, 1995, 270 (5237) :815-819
[2]  
Anderson WF, 1998, NATURE, V392, P25
[3]  
BAICHWAL VR, 1986, GENE TRANSFER, P148
[4]   THERAPEUTIC GENE DELIVERY IN HUMAN BETA-LYMPHOBLASTOID CELLS BY ENGINEERED NON-TRANSFORMING INFECTIOUS EPSTEIN-BARR-VIRUS [J].
BANERJEE, S ;
LIVANOS, E ;
VOS, JMH .
NATURE MEDICINE, 1995, 1 (12) :1303-1308
[5]   EFFICIENT CDNA CLONING BY DIRECT PHENOTYPIC CORRECTION OF A MUTANT HUMAN CELL-LINE (HPRT-) USING AN EPSTEIN-BARR VIRUS-DERIVED CDNA EXPRESSION VECTOR [J].
BELT, PBGM ;
JONGMANS, W ;
DEWIT, J ;
HOEIJMAKERS, JHJ ;
VANDEPUTTE, P ;
BACKENDORF, C .
NUCLEIC ACIDS RESEARCH, 1991, 19 (18) :4861-4866
[6]   Improvement of erythropoiesis in β-thalassemic mice by continuous erythropoietin delivery from muscle [J].
Bohl, D ;
Bosch, A ;
Cardona, A ;
Salvetti, A ;
Heard, JM .
BLOOD, 2000, 95 (09) :2793-2798
[7]   The potential of extrachromosomal replicating vectors for gene therapy [J].
Calos, MP .
TRENDS IN GENETICS, 1996, 12 (11) :463-466
[8]   Safety-modified episomal vectors for human gene therapy [J].
Cooper, MJ ;
Lippa, M ;
Payne, JM ;
Hatzivassiliou, G ;
Reifenberg, E ;
Fayazi, B ;
Perales, JC ;
Morrison, LJ ;
Templeton, D ;
Piekarz, RL ;
Tan, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (12) :6450-6455
[9]   Improvement of mouse β-thalassemia upon erythropoietin delivery by encapsulated myoblasts [J].
Dalle, B ;
Payen, E ;
Regulier, E ;
Deglon, N ;
Rouyer-Fessard, P ;
Beuzard, Y ;
Aebischer, P .
GENE THERAPY, 1999, 6 (02) :157-161
[10]  
DEMPAMPHILIS ML, 1996, DNA REPLICATION EUKA, P45